Immunotherapy in the treatment of food allergy. Does it have a future?

Allergologia et Immunopathologia

Volumn 37, Issue 3, 2009, Pages 143-145

  Enrique, Ernesto ^a  

^a Castellon General Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; DNA FRAGMENT; FOOD ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 10; NATURAL PRODUCT; PLACEBO; TOLL LIKE RECEPTOR;

ADJUVANT THERAPY; ARTICLE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIET RESTRICTION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FOOD ALLERGY; GENETIC ENGINEERING; HAZELNUT; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; LANGERHANS CELL; MEDICAL DECISION MAKING; MOUTH MUCOSA; PATIENT SAFETY; PEANUT ALLERGY; PROVOCATION TEST; PUBLIC HEALTH PROBLEM; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; RISK REDUCTION; TH1 CELL; TRADITIONAL MEDICINE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; ANTIBODY FORMATION; CLINICAL TRIALS AS TOPIC; DESENSITIZATION, IMMUNOLOGIC; DRUGS, CHINESE HERBAL; FOOD HABITS; FOOD HYPERSENSITIVITY; GENETIC ENGINEERING; HUMANS; IMMUNOGLOBULIN E; IMMUNOLOGIC FACTORS; RESPIRATORY HYPERSENSITIVITY; TH2 CELLS;

EID: 67650754959     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/S0301-0546(09)71726-4     Document Type: Article

References (47)

1. Enrique E., and Cisteró-Bahíma A. Curr Opin Allergy Clin Immunol 6 (2006) 466-469
2. Burks A.W., Laubach S., and Jones S.M. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol 121 (2008) 1344-1350
3. Noon L., and Cantab B. Prophylactic inoculation against hay fever. Lancet 177 (1911) 1572-1573
4. Bousquet J., Lockey R.F., and Malling H.J. Allergen immunotherapy WHO position paper. Allergy 54 Suppl. 52 (1998) 20-22
5. Durham S.R., Walker S.M., Varga E.M., et al. Longterm clinical efficacy of grass pollen immunotherapy. N Engl J Med 341 (1999) 468-475
6. Freeman J. "Rush" inoculation, with special reference to hay fever treatment. Lancet 215 (1930) 744-747
7. Oppenheimer J.J., Nelson H.S., Bock S.A., et al. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 90 (1992) 256-262
8. Nelson H.S., Lahr J., Rule R., et al. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 99 (1997) 744-751
9. Kelso J.M., Jones R.T., Tellez R., and Yunginger J.W. Oral allergy syndrome successfully treated with pollen immunotherapy. Ann Allergy Asthma Immunol 74 (1995) 391-396
10. Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitivity patients. Clin Exp Allergy 28 (1998) 1368-1373
11. Asero R. Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy. Ann Allergy Asthma Immunol 84 (2000) 460-462
12. Kazemi-Shirazi L., Pauli G., Purohit A., et al. Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol 105 (2000) 116-125
13. Bucher X., Pichler W.J., Dahinden C.A., and Helbling A. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Allergy 59 (2004) 1272-1276
14. Bolhaar S.T., Tiemessen M.M., Zuidmeer L., et al. Efficacy of birchpollen immunotherapy on cross-reactive food allergy confirmed by skin test and double-blind food challenges. Clin Exp Allergy 34 (2004) 761-769
15. Hansen K.S., Khinchi M.S., Skov P.S., Bindslev-Jensen C., Poulsen L.K., and Malling H.J. Food allergy to apple and specific immunotherapy with birch pollen. Mol Nutrition 48 (2004) 441-448
16. Kinaciyan T., Jahn-Schmid B., Radakovics A., Zwölfer B., Schreiber C., Francis J.N., Ebner C., and Bohle B. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. J Allergy Clin Immunol 119 (2007) 937-943
17. Bieber T. Allergen-specific sublingual immunotherapy: less mystic, more scientific. Allergy 61 (2006) 149-150
18. Wilson D.R., Lima M.T., and Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 60 (2005) 4-12
19. Kleine-Tebbe J., Ribel M., and Herold D.A. Safety of a SQ-standardized grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial. Allergy 61 (2006) 181-184
20. Dahl R., Stender A., and Rak S. Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis. Allergy 61 (2006) 185-190
21. Durham S.R., Yang W.H., Pedersen M.R., et al. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 117 (2006) 802-809
22. Moingeon P., Batard T., Fadel R., et al. Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61 (2006) 151-165
23. Francis J.N., Till S.J., and Durham S.R. Induction of IL-10+ CD4+ CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol 111 (2003) 1256-1261
24. Allam J.P., Novak N., Fuchs C., et al. Characterization of dendritic cells from human oral mucosa: a new Langerhans cell type with high constitutive Fc epsilon RI expression. J Allergy Clin Immunol 112 (2003) 141-148
25. Allam J.P., Niederhagen B., Bucheler M., et al. Comparative analysis of nasal and oral mucosa dendritic cells. Allergy 61 (2006) 166-172
26. Enrique E., Pineda F., Malek T., et al. Sublingual immunotherapy for hazelnut food allergy: a randomized double-blind placebo- controlled study with a standardized hazelnut extract. J Allergy Clin Immunol 116 (2005) 1073-1079
27. Fernández-Rivas M, Garrido-Fernández S, Nadal JA, Alonso Díaz de Durana MD, García BE, González-Mancebo E, et al. Randomized double-blind, placebo-controlled trial of sublingual immunotherapy with a Pru p 3 quantified peach extract. Allergy 2009. (in press).
28. Li X.M., Zhang T.F., Huang C.K., et al. Food allergy herbal formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 108 (2001) 639-646
29. Li X.M., and Sampson H.A. Novel approaches for the treatment of food allergy. Curr Opin Allergy Clin Immunol 2 (2002) 273-278
30. Srivastava K.M., Kattan J.D., Zou Z.M., et al. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut Allergy. J Allergy Clin Immunol 115 (2005) 171-178
31. Milgrom H. Anti-IgE therapy in allergic disease. Inflamm Allergy Drug Targets 5 (2006) 23-34
32. Leung D.Y., Sampson H.A., Yunginger J.W., et al. N Engl J Med 348 (2003) 986-993
33. Casale T.B., Busse W.W., Kline J.N., et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol 117 (2006) 134-140
34. Neudecker P., Lehmann K., Nerkamp J., et al. Mutational and structural epitope analysis of Pru av 1 and Api g 1, the major aller gens of cherry and celery: correlating IgE-reactivity with three-dimensional structure. Biochem J 376 (2003) 97-107
35. Wiche R., Gubesch M., Köning H., et al. Molecular basis of pollen-related food allergy: identification of a second cross-reactive IgE epitope on Pru av 1, the major cherry allergen. Biochem J 385 (2005) 319-327
36. Reese G., Viebranz J., Leong-Kee S.M., et al. Reduced allergenic potency of VR9-1, a mutant of the major shrimp allergen Pen a 1 (tropomyosin). J Immunol 175 (2005) 8354-8364
37. Bolhaar S.T., Zuidmeer L., Ma Y., et al. A mutant of the major apple allergen, Mal d 1, demonstrating hypo-allergenicity in the target organ by double-blind placebo-cotrolled food challenge. Clin Exp Allergy 35 (2005) 1638-1644
38. Tada Y., Nakase M., Adachi T., et al. Reduction of 14-16 kDa allergenic proteins in transgenic rice plants by antisense gene. FEBS Lett 391 (1996) 341-345
39. Hermann E.M., Helm R.M., Jung R., and Kinney A.J. Genetic modification reduces an immunodominant allergen from soybean. Plant Physiol 132 (2003) 36-43
40. Gilissen L.H., Bolhaar S.T., Matos C.I., et al. Silencing the major apple allergen Mal d 1 by using the RNA interference approach. J Allergy Clin Immunol 115 (2005) 364-369
41. Le L.Q., Lorenz Y., Scheurer S., et al. Design of tomato fruits with reduced allergenicity by dsRNAi-mediated inhibition of ns-LTP (Lyc e 3) expression. Plant Biotech J 4 (2006) 231-242
42. Li X.M., Srivastava K., Grishin A., et al. Persistent protective effect of heat-killed Escherichia coli producing 'engineered' recombinant peanut proteins in a murine model of peanut allergy. J Allergy Clin Immunol 112 (2003) 159-167
43. Li X.M., Serebrisky D., Lee S.Y., et al. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. J Allergy Clin Immunol 106 (2000) 150-158
44. Ballmer-Weber B.K., Scheurer S., Fritsche P., et al. Component-resolved diagnosis with recombinant allergens in patients with cherry allergy. J Allergy Clin Immunol 110 (2002) 167-173
45. Reuter A., Lidholm J., Andersson K., et al. A critical assessment of allergen component-based in vitro diagnosis in cherry allergy across Europe. Clin Exp Allergy 36 (2006) 815-823
46. Batard T., Didierlaurent A., Chabre H., et al. Characterization of recombinant wild-type Bet v 1 as a candidate vaccine against birch pollen Allergy. Int Arch Allergy Immunol 136 (2005) 239-249
47. Pons L., Palmer K., and Burks W. Towards immunotherapy for peanut allergy. Curr Opin Allergy Clin Immunol 5 (2005) 558-562